Capital Investment Advisory Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-500
Closed -$10K – 1000
2019
Q3
$10K Hold
500
– – ﹤0.01% 985
2019
Q2
$12K Hold
500
– – ﹤0.01% 919
2019
Q1
$10K Hold
500
– – ﹤0.01% 834
2018
Q4
$6K Buy
+500
New +$7.45K ﹤0.01% 905

Other funds holding NEO

Capital Investment Advisory Services's NEO Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 500 shares — an estimated $10K sold.

Capital Investment Advisory Services first reported a position in NEO in Q4 2018 and held it in 4 quarters. The position peaked at $12K in Q2 2019. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 500 NeoGenomics shares in Q4 2019, an estimated $10K.
  • Capital Investment Advisory Services first reported a position in NeoGenomics in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's NeoGenomics position peaked at $12K in Q2 2019.
  • 261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.